Chenhao Xu, Da Huo, Yanxu Liu, Qiyu Zhu, Junjie Zhao, Jiayu Liang, Xianding Wang
{"title":"Allostatic load and kidney cancer incidence and mortality: a genetic susceptibility and proteomic mediation analysis.","authors":"Chenhao Xu, Da Huo, Yanxu Liu, Qiyu Zhu, Junjie Zhao, Jiayu Liang, Xianding Wang","doi":"10.1186/s12885-025-14980-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Allostatic load (AL), reflecting chronic physiological stress across neuroendocrine, immune, and metabolic systems, may contribute to the onset and prognosis of multiple cancers via inflammation and stress-related injury. However, the associations between AL and kidney cancer (KC) remain unclear. And large-scale evidence linking AL to KC risk, prognosis, and molecular mechanisms is lacking.</p><p><strong>Methods: </strong>In this Prospective UK Biobank cohort study, 334,754 Participants were analyzed for KC incidence, 357 KC Patients for mortality, and 36,120 participants for proteomic mediation. Proteomic mediation was performed using Med4way analysis; protein trajectories were analyzed using locally weighted regression smoothing (LOESS) regression. The expression profiles of key mediator genes were validated by single-cell RNA sequencing. Enrichment analyses were conducted to characterize mediator proteins by biological pathways, tissue specificity, and cell-type distribution. An AL-mediated proteins-based prediction model was developed via LASSO-Cox regression.</p><p><strong>Results: </strong>During mean follow-up of 13.2 years, participants in the highest AL quintile had increased KC incidence (HR 1.70, 95% CI 1.38-2.10). Among KC patients, high AL was associated with increased mortality (HR 3.10, 95% CI 1.51-6.36). Proteins mediating AL-KC associations included HAVCR1, GDF15, TNFRSF11A, FSTL3, and CD83; HAVCR1 showed strongest mediation (72.69%) and distinct pre-diagnostic trajectory. Functional enrichment revealed these proteins were jointly involved in immune regulation, stress response, and epithelial signaling pathways. The predictive model incorporating NOS3, SULT2A1, HAVCR1, FSTL3, and sex achieved robust performance (10-year AUC 0.80) for KC Prediction.</p><p><strong>Conclusions: </strong>AL is associated with increased KC incidence and mortality, mediated through inflammatory and metabolic proteins. These findings underscore chronic physiological stress as a significant factor in KC pathogenesis, providing potential biomarkers for early risk assessment and targeted prevention.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":"25 1","pages":"1575"},"PeriodicalIF":3.4000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12523015/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-025-14980-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Allostatic load (AL), reflecting chronic physiological stress across neuroendocrine, immune, and metabolic systems, may contribute to the onset and prognosis of multiple cancers via inflammation and stress-related injury. However, the associations between AL and kidney cancer (KC) remain unclear. And large-scale evidence linking AL to KC risk, prognosis, and molecular mechanisms is lacking.
Methods: In this Prospective UK Biobank cohort study, 334,754 Participants were analyzed for KC incidence, 357 KC Patients for mortality, and 36,120 participants for proteomic mediation. Proteomic mediation was performed using Med4way analysis; protein trajectories were analyzed using locally weighted regression smoothing (LOESS) regression. The expression profiles of key mediator genes were validated by single-cell RNA sequencing. Enrichment analyses were conducted to characterize mediator proteins by biological pathways, tissue specificity, and cell-type distribution. An AL-mediated proteins-based prediction model was developed via LASSO-Cox regression.
Results: During mean follow-up of 13.2 years, participants in the highest AL quintile had increased KC incidence (HR 1.70, 95% CI 1.38-2.10). Among KC patients, high AL was associated with increased mortality (HR 3.10, 95% CI 1.51-6.36). Proteins mediating AL-KC associations included HAVCR1, GDF15, TNFRSF11A, FSTL3, and CD83; HAVCR1 showed strongest mediation (72.69%) and distinct pre-diagnostic trajectory. Functional enrichment revealed these proteins were jointly involved in immune regulation, stress response, and epithelial signaling pathways. The predictive model incorporating NOS3, SULT2A1, HAVCR1, FSTL3, and sex achieved robust performance (10-year AUC 0.80) for KC Prediction.
Conclusions: AL is associated with increased KC incidence and mortality, mediated through inflammatory and metabolic proteins. These findings underscore chronic physiological stress as a significant factor in KC pathogenesis, providing potential biomarkers for early risk assessment and targeted prevention.
背景:适应负荷(AL)反映了神经内分泌、免疫和代谢系统的慢性生理应激,可能通过炎症和应激相关损伤参与多种癌症的发病和预后。然而,AL与肾癌(KC)之间的关系尚不清楚。目前还缺乏将AL与KC风险、预后和分子机制联系起来的大规模证据。方法:在这项前瞻性英国生物银行队列研究中,对334,754名参与者进行了KC发病率分析,对357名KC患者进行了死亡率分析,对36,120名参与者进行了蛋白质组学调解。采用Med4way分析进行蛋白质组学调解;使用局部加权回归平滑(黄土)回归分析蛋白质轨迹。通过单细胞RNA测序验证了关键中介基因的表达谱。富集分析通过生物学途径、组织特异性和细胞类型分布来表征中介蛋白。通过LASSO-Cox回归建立基于al介导的蛋白预测模型。结果:在平均13.2年的随访期间,AL最高五分位数的参与者KC发病率增加(HR 1.70, 95% CI 1.38-2.10)。在KC患者中,高AL与死亡率增加相关(HR 3.10, 95% CI 1.51-6.36)。介导AL-KC关联的蛋白包括HAVCR1、GDF15、TNFRSF11A、FSTL3和CD83;HAVCR1表现出最强的中介作用(72.69%)和明显的诊断前轨迹。功能富集表明这些蛋白共同参与免疫调节、应激反应和上皮信号通路。结合NOS3、SULT2A1、HAVCR1、FSTL3和性别的预测模型在KC预测中取得了稳健的表现(10年AUC为0.80)。结论:AL通过炎症和代谢蛋白介导与KC发病率和死亡率增加相关。这些发现强调了慢性生理应激是KC发病机制的重要因素,为早期风险评估和有针对性的预防提供了潜在的生物标志物。
期刊介绍:
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.